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Extracellular matrix proteins are potent 
agonists of human smooth muscle 
cell migration 
Peter R. Nelson, MD,  Shinji Yamamura, MD,  and K. Craig Kent, MD,  Boston, Mass. 
Purpose: Extracellular matrix proteins can stimulate smooth muscle cell (SMC) migration 
by three distinct mechanisms: chemokinesis (nondirected migration in the presence of 
soluble protein), chemotaxis (directed migration toward soluble protein), and haptotaxis 
(directed migration toward insoluble, substrate-bound protein). This study investigates 
the effects of four prevalent extracellular matrix proteins (collagen types I and IV, 
fibronectin, and laminin), and platelet-derived growth factor (PDGF) on haptotaxis, 
chemotaxis, and chemokinesis ofhuman SMCs. The role of large guanosine triphosphate- 
binding proteins (G-proteins) in the signaling mediating these effects is also evaluated. 
Methods: Human saphenous vein SMCs were used in all migration studies. Chemokinesis, 
chemotaxis, and haptotaxis to each of the matrix proteins were measured and compared 
with PDGF through the use of a 48-well microchemotaxis chamber. The role of G-proteins 
in matrix-induced SMC migration was studied with the modulators of G-protein function, 
cholera and pertussis toxins. 
Results: For all matrix proteins the relative strength of the various timuli for migration was 
haptotaxis > chemotaxis >chemokinesis (p < 0.05). For all three stimuli collagen I and IV 
produced the most significant migration followed by fibronectin > PDGF-AB > laminin 
(p < 0.05). Pertussis toxin completely inhibited chemotaxis and partially inhibited 
haptotaxis by laminin but did not affect migration by other matrix proteins, whereas 
cholera toxin abolished migration in response to all four matrix proteins. 
Conclusion: Matrix proteins, with the exception of laminin, provide a moresignificant 
stimulus for SMC locomotion than does the prototypical gonist, PDGF-AB. Of the three 
mechanisms by which migration can be stimulated, haptotaxis elicits the most pro- 
found effect. The importance of G-proteins as second messengers for migration varies with 
each matrix protein and with the mechanism of stimulation. (J Vasc Surg 1996;24: 
25-33.) 
Despite advances in treatment modalities, arterio- 
sclerotic vascular disease remains the leading cause of 
morbidity and mortality in the United States. The 
excellent initial rate of success of  vascular reconstruc- 
tion is later diminished by restenosis related to intimal 
hyperplasia) ,2 Smooth muscle cell (SMC) migration 
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and proliferation and the production of abundant 
extracellular matrix (ECM) are necessary steps in this 
pathologic process. 3 Although the hyperplastic re- 
sponse that follows arterial reconstruction is complex, 
migration of vascular SMCs from the arterial media to 
the intima is necessary for the development of an 
intimal plaque. Animal studies have shown that up to 
50% of SMCs in the hyperplastic neointima re not 
dividing, 4 suggesting that their presence in the sub- 
intimal space is related to migration. 
SMCs are stimulated to migrate by a plethora 
of cytoldnes and growth factors. Platelet-derived 
growth factor (PDGF) is considered the prototypical 
agonist of SMC migration. Although a number of 
these factors including PDGF are released at the time 
of arterial injury, SMCs are also simultaneously ex- 
posed to a variety of matrix proteins. ~In the un- 
injured vessel wall the ECM forms the latticework in 
which medial SMCs reside. After arterial injury oc- 
25 
JOURNAL OF VASCULAR SURGERY 
26 Nelson, Yamamura, and Kent ~uly 1996 
curs, the kind, quantity, and distribution of these 
matrix proteins change. Therefore matrix proteins 
may greatly contribute to the alterations in SMC 
phenotype that lead to the development of intimal 
hyperplasia. 
The influence of ECM proteins on SMC migra- 
tion has not been well studied. Experiments o date 
have focused primarily on attachment of SMC to 
various matrix-coated surfaces. 6 The relative influ- 
ence of the most prevalent matrix proteins on SMC 
migration is not known, nor has the magnitude of 
the effect of matrix proteins on SMC migration been 
compared with that of soluble growth factors. 
The effect of an agonist on cellular migration can 
differ significantly depending on the distribution 
and physical state of the stimulant. Three distinct 
stimuli of migration have been described. Chemold- 
nesis refers to nondirected cellular migration in re- 
sponse to a soluble factor (in the absence of a 
concentration gradient). Chemotaxis describes di- 
rected migration toward apositive gradient of soluble 
agonist. Haptotaxis defines directed cellular migra- 
tion toward an insoluble attractant such as a substrate- 
bound matrix protein. By far, chemotaxis is the most 
widely studied of the three mechanisms ofmigration, 
and significantly less is known about haptotaxis. 
Which of these three modalities of stimulation has the 
greatest influence on SMC migration after arterial 
injury is currently unlmown, although theoretically all
three forms may be important. 
Matrix proteins promote cellular migration by 
activating a series of intracellular signaling events. 
Although these pathways are poorly understood, 
there is increasing evidence that suggests hat hetero- 
trimeric guanosine triphosphate (GTP)-binding pro- 
teins (G-proteins) may have an important role in this 
process. 7 Large G-proteins facilitate communication 
between cell-surface receptors and a series of intra- 
cellular messengers through modification ofion chan- 
nels and phospholipid metabolism. Studies in neo- 
plastic cell lines demonstrate a role for G-proteins in 
mediating metastatic migration in response to matrix 
proteins. 8 
This study was designed to investigate he effects 
of a series of ECM proteins on human SMC migra- 
tion. The goals were as follows: (1) to determine the 
relative strength of the migratory response licited by 
four prevalent ECM proteins, (2) to compare the 
influence of matrix proteins on SMC migration with 
that of PDGF, (3) to determine which of the three 
stimuli for migration ismost poFent, and (4) to define 
the importance of membrane G-proteins in the sig- 
naling cascade that leads to matrix protein-induced 
migration. 
MATERIAL AND METHODS 
General materials. Human recombinant 
PDGF-AB was obtained from Upstate Biotechnolo- 
gies Inc. (Lake Placid, N. Y.). Bovine fibronectin, 
Engelbreth-Holm-Swarm mouse sarcoma laminin, 
calf skin collagen I, human placental collagen IV, 
and the smooth muscle-specific actin immuno- 
staining ldt were obtained from Sigma Chemical 
Co. (St. Louis, Mo.). Pertussis toxin (PT), cholera 
toxin (CT), Dulbecco's modified Eagle's medium 
(DMEM), phosphate-buffered saline solution (PBS), 
fetal bovine serum, trypsin-ethylenediaminetet- 
raacetic acid, penicillin/streptomycin/fungizone so- 
lution, L-glutamine, and N-2-hydroxyethylpipera- 
zine-N-2-ethanesulfonic acid were obtained from 
GIBCO BRL Life Technologies (Gaithersburg, 
Md.). Polycarbonate 8 gm pore membranes were 
from Poretics Corp. (Livermore, Calif.). 
Cell culture. Human SMCs were harvested from 
explants of remnant portions of saphenous vein in- 
tended for aortocoronary or peripheral rterial bypass 
grafting as previously described. 9 Sections of saphe- 
nous vein were opened lengthwise, and the endothe- 
lial and adventitial layers were gently removed. Frag- 
ments of the medial ayer were placed onto tissue 
culture plates, and outward growing SMCs were 
harvested and subcultured. Cells were maintained at
37 ° C and 5% CO 2 in DMEM supplemented with 10% 
fetal bovine serum, 25 mmol/L N-2-hydroxyeth- 
ylpiperazine-N-2-ethanesulfonic acid, 40 U/ml peni- 
cillin G, 40 btg/ml streptomycin, 100 ng/ml ampho- 
tericin B, and 4.8 mmol/L L-glutamine. Cells in 
passages one to five were used for all experimentation. 
SMC identity was verified by immunostaining with 
anti-human ~-actin antibody and by a characteristic 
hill-and-valley growth pattern. 
Migration assay. Before migration experiments 
were conducted, SMCs were grown to confluence in
100 mm culture dishes and were then made quiescent 
by incubation in serum-free DMEM for 72 hours. 
Cells were then washed in PBS, harvested with 0.05% 
trypsin-ethylenediaminetetraacetic acid, and resus- 
pended in serum-free DMEM. 
Migration assays were performed for 4 hours at 
37 ° C in a 48-well microchemotaxis chambers (Neu- 
roprobe, Cabin John, Md.) with upper and lower 
wells separated by polycarbonate 8 btm pore mem- 
branes. For all assays SMCs suspended in serum-free 
DMEM were seeded at a density of 50,000/well 
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(6000/ram 2)into the upper wells of the chamber. For 
chemokinesis experiments soluble agonists diluted in 
serum-free DMEM were introduced into the upper 
and lower wells. For chemotaxis agonists diluted in 
DMEM were added to the lower well, and vehicle 
diluted in DMEM was added to the upper well. In 
preparation for the haptotaxis experiments mem- 
branes were floated on ECM proteins in PBS in the 
concentrations indicated for 48 hours at 4 ° C. Mem- 
branes were then rinsed with PBS, air dried, and 
placed into the microchemotaxis chamber with the 
coated surface facing downward. Control membranes 
were floated on PBS alone and handled in the same 
manner. Cell suspension was then added to the upper 
well, and DMEM alone was added to the lower well of 
the chamber. 
On completion of the assay the membrane was 
removed from the chamber, fixed in 70% ethyl alcohol 
at -20 ° C for 20 minutes, and stained in hematoxylin 
overnight. The upper side of the membrane was then 
examined for cell attachment and scraped with a 
cotton swab; care was taken not to disturb cells that 
had migrated onto the undersurface. The membrane 
was then mounted to a microscope slide for viewing, 
and the migration in each well was assessed by 
counting the number of cells in five independent 
high-power fields at 200× magnification. The stimu- 
latory effect of the various agonists was expressed 
either as the number of cells migrated or as the 
fold-increase in migration over unstimulated control 
samples. 
Effect of  cholera and pertussis toxins. In ex- 
periments investigating the role of G-proteins in the 
signaling of matrix-stimulated SMC migration, CT 
(10 ~tg/ml) or PT (! Bg/ml) was added to the 
serum-free DMEM cell suspension i  the upper well 
of the chamber coincident with sccding. Standard 
chemotaxis and haptotaxis assays were then per- 
formed as described previously, and the effect of the 
toxins on SMC migration was determined asa percent 
of agonist-stimulated control samples in the absence 
of toxin ,(vehicle only). 
Statistical analysis. Individual experiments wcrc 
performed in triplicate, and all observations were 
made with at least three separate cell lines. Values 
arc displayed as the mean+SD,  and statistical 
comparisons were made with an unpaired Student's 
t test with StatView (Brain Power, Inc., Calabaras, 
Calif.) software on a personal computer. For com- 
parisons, p values of less than 0.05 were considered 
significant. Data displayed arc representative ex- 
amples. 
RESULTS 
Concentration-response effects of  ECM pro- 
teins. To directly compare the influence of the various 
ECM proteins on human SMC migration, we first 
created concentration-response curves for each pro- 
tein for each of the three stimuli and then used in 
separate comparative studies the concentrations that 
produced maximal migration. Accordingly, concen- 
tration-response curves were created for collagens I 
and IV, fibronectin, and laminin for chemokinesis, 
chemotaxis, and haptotaxis (Fig. 1). For chemokinesis 
and chemotaxis the concentrations oted indicate the 
actual concentration of ECM protein to which the 
SMCs were exposed uring the assay. For haptotaxis, 
concentrations reported refer to the concentration of
ECM protein in the PBS solution on which mem- 
branes were floated during coating. Because these 
values do not indicate the actual concentration of 
ECM protein adsorbed to the membrane surface, 
they cannot be compared numerically with values for 
chemokinesis or chemotaxis. In addition, we found 
no difference in attachment of cells to membranes 
floated on any of the four matrix proteins or to control 
membranes floated on PBS alone. 
Laminin had no significant chemoldnetic effect 
throughout the range of concentrations tested. For 
chemotaxis and haptotaxis laminin concentration re- 
sponse curves plateaued once a maximal effect was 
achieved (Fig. 1). A similar plateau was achieved with 
chemokinesis, chemotaxis, and haptotaxis nresponse 
to fibronectin. The concentration-response curves for 
the two types of collagen were notably different 
from those seen with laminin and flbronectin. For 
chemoldnesis, chemotaxis, and haptotaxis, migration 
diminished in response to concentrations of protein 
that were higher than those necessary to achieve a 
maximal response. We have previously observed maxi- 
mal stimulation of SMC migration to PDGF-AB at a 
concentration of 5 ng /ml?  Concentrations of each 
protein that provided a maximal response were used 
in all subsequent comparative assays. 
Comparison of  chemokinesis, chemotaxis, and 
haptotaxis. The relative strength of the three stimuli 
for migration (chemokinesis, chemotaxis, and hap- 
totaxis) is unknown. Direct comparisons among 
chemokinesis, chemotaxis, and haptotaxis were made 
for each protein (Fig. 2). The relationship was similar 
for all four ECM proteins. Haptotaxis produced a 
significantly greater migratory response than did 
chemotaxis, which in turn was a more potent stimu- 
lus for SMC migration than was chemokinesis 
(p < 0.05 for all differences). 
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Fig. 1. Concentration-response curves for migration of human SMCs to ECM proteins. 
Human SMCs were stimulated by ECM proteins in indicated concentrations, and chemokinesis 
(D), chemotaxis (•), and haptotaxis (o) were measured asdescribed in the Material and Methods 
section. Results are expressed ascells that have migrated +SD. Experiments were performed in
triplicate and repeated in at least three cell ines from different donors. Data from a representative 
experiment is shown. 
Comparison of ECM proteins. We assessed the 
relative ffect on SMC migration of the various ECM 
proteins and PDGF-AB (Fig. 3). Comparisons with 
PDGF-AB could be made only for chemokinesis and 
chemotaxis. In a representative experiment displayed 
in Fig. 3 collagen IV produced a more potent re- 
sponse than did collagen I for all three forms of 
stimulation (p < 0.05). However, this relationship 
was not consistent, and in some experiments colla- 
gen I and collagen IV were equally potent. Both 
types of collagen consistently produced more mi- 
gration than fibronectin (p < 0.05), which had a 
stronger influence on migration than did laminin 
(p < 0.05). The chemokinetic and chemotactic effect 
of PDGF-AB was intermediate b tween laminin and 
fibronectin (p < 0.05). With the exception of lami- 
nin the ECM proteins induced afar more significant 
migratory response than did the prototypical gonist 
of migration, PDGF-AB. 
Role of GTP-binding proteins. We hypothe- 
sized that differences incell locomotion produced by 
the various matrix proteins might be related to 
differential ctivation of cellular signaling pathways. A 
significant role for the large G-proteins in ECM- 
induced movement of tumor cells has been de- 
scribed. 7,s To evaluate the importance of G-proteins 
in ECM-induced SMC migration, we used two 
agents: CT, which adenosine diphosphate-ribosylates 
the G-protein stimulatory subunit (Gs) , resulting in 
persistent activation of adenylate cyclase and produc- 
tion of cyclic-adenosine monophosphate (cAMP), 
and PT, which adenosine diphosphate-ribosylates n 
inhibitory subunit (Gi) , preventing its interaction 
with membrane receptors) ° SMC and toxins were 
introduced simultaneously. CT (10 pg/ml) pro- 
foundly inhibited SMC migration in response to all 
agonists (Fig. 4, p < 0.05 for all comparisons) and 
even eliminated baseline migration in unstimulated 
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Fig. 2. Comparison of migratory effects ofchemokinesis, 
chemotaxis, and haptotaxis. Human SMCs were stimulated 
with ECM proteins in concentrations that provided maxi- 
mal chemoldnesis (CK), chemotaxis (CT), and haptotaxis 
(HT). Results are expressed as fold-increase in migration 
versus unstimulated control _+ SD. Experiments were per- 
formed in triplicate and repeated in at least hree cell lines 
from different donors. Data from a representative experi- 
ment is shown (p < 0.05, *CK compared with CT; **CT 
compared with HT). 
cells (data not shown) in the control group. PT 
(1 gg /ml )  had no effect on chemotaxis or haptotaxis 
to fibronectin, collagen I, or collagen IV. However, 
PT partially inhibited haptotaxis (26% + 10%) and 
completely eliminated chemotaxis to laminin (Fig. 4, 
p < 0.05 for both differences). 
D ISCUSSION 
At the time of arterial injury SMCs are simulta- 
neously exposed to multiple growth factors and to a 
host ofextracellular matrix proteins. The effect of the 
former on SMC migration has been thoroughly 
evaluated; however, less is lmown about the influence 
of matrix proteins on SMC locomotion. This study 
evaluates the effect of four predominant extracellular 
matrix proteins on migration of human vascular 
SMCs. We chose to study SMCs derived from human 
saphenous vein because of the relevance of these cells 
to stenoses that develop after autogenous arterial 
reconstruction. 
Evaluation of the effect of matrix proteins on SMC 
migration is potentially complex, because the stimu- 
lus for migration can vary with the solubility of  the 
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Fig. 3. Comparison of migratory effects of laminin, fi- 
bronectin, and collagen I and IV. Migration of human 
SMCs exposed to laminin (Lm), fibronectin (Fn), collagen 
type I (CnI), and collagen type IV (CnIV) with concentra- 
tions for each that produced maximal effect. PDGF-AB was 
also used in comparisons ofchemoldnesis and chemotaxis. 
Results are expressed as fold-increase in migration versus 
unstimulated control + SD. Experiments were performed 
in triplicate and repcated in at least three cell lines from 
different donors. Data from a representative experiment is 
shown (p < 0.05, *PDGF compared with Lm, **Fn com- 
pared with PDGF or Lm, # Cn I or IV compared with Fn). 
agonist and its location relative to the affected cell. 
Three different forms of migration have been defined. 
I f  a gradient of soluble agonist does not exist, SMC 
will be stimulated to migrate in a random fashion 
(chemokinesis). Directed migration toward a soluble 
attractant (growth factor or matrix protein) is termed 
chemotaxis, and haptotaxis defines migration of cells 
toward a gradient provided by an insoluble protein 
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Fig. 4. Effect of cholera nd pertussis toxins on chemo- 
taxis and haptotaxis. Human SMCs, coincubated with CT 
(10 gg/ml) or PT (1 gg/ml), were exposed to either 
chemotacfic or haptotactic stimulus of fibronectin (Fn), 
laminin (Lm), collagen type I (CnI), or collagen type IV 
(CnlV). Results are expressed as percent of control (vehicle 
only) chemotaxis/haptotaxis to each of the proteins _+ SD. 
Experiments were performed intriplicate and repeated inat 
least three cell lines from different donors. Data from a 
representative experiment is shown (p < 0.05, *CT com- 
pared with control; **PT compared with control). 
(ECM protein). All three stimuli could potentially 
influence the vascular SMCs during the remodeling 
process that follows an arterial injury? Autocrine 
release of growth factors uch as PDGF might stimu- 
late SMC migration via chemokinesis. Circulating 
blood products (both growth factors and soluble 
matrix proteins) present at the luminal surface of an 
injured artery can provide a directional stimulus for 
SMC migration (chemotaxis). These same matrix 
proteins, once substrate-bound, or insoluble matrix 
proteins that make up the basement membrane, may 
also provide a haptotactic stimulus for migration. To 
evaluate these various mechanisms of migration we 
used four agonists, fibronectin, laminin, and collagen 
types I and IV, all of which are prominent components 
of either the extracellular matrix or basement mem- 
brane. 
In an initial series of studies we determined the 
concentration of each matrix protein that for each 
migratory stimulus resulted in maximal cell move- 
ment. With these concentrations we were able to 
make valid comparisons between the migratory re- 
sponses elicited by each protein and each stimulus. 
Migration in response to fibronectin and laminin 
peaked at intermediate concentrations and then pla- 
teaued when SMCs were stimulated with higher 
concentrations of these proteins. Presumably a con- 
centration was reached where integrin receptors were 
saturated, preventing higher concentrations of these 
matrix proteins from producing any additional effect. 
In contrast, for collagens I and IV maximal migration 
was produced by intermediate concentrations of pro- 
tein, and migration diminished when higher concen- 
trations of collagen were used. Similar observations 
were made by DiMilla et al.,n who found that 
increasing concentrations of collagen IV enhanced 
SMC attachment but diminished the ability of the 
SMCs to migrate. They hypothesized that the ability 
of a cell to migrate is inversely related to its potential 
to attach. It is unclear why the concentration response 
curves for the collagens and laminin and fibronectin 
differ; however, this observation provides additional 
evidence that the effect of matrix components on 
SMC migration is specific for each protein. 
The strongest migratory response followed stimu- 
lation of SMC by the two collagens; fibronectin was 
intermediate in strength, and laminin provided the 
least potent stimulus for migration. This hierarchy 
was identical for chemoldnesis, chemotaxis, and hap- 
totaxis. Previous studies have revealed differential 
effects of matrix proteins on SMC phenotype. Fi- 
bronectin has been shown to convert SMC from a 
differentiated contractile state to a synthetic and 
proliferative phcnotype. 12 Our observation of a 
strong stimulatory effect of fibronectin on SMC 
migration is consistent with this ability offibronectin 
to transform vascular SMCs. Both forms of collagen 
were also potent agonists of migration. Even laminin 
stimulated migration of human SMC, albeit o a much 
lesser degree. However, laminin and the collagens 
have been shown by others to inactivate SMC and 
promote differentiation. 12 The reason for these dis- 
crepant findings is unclear; however, the effect of 
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these matrix proteins on SMC migration was repro- 
ducible wil:h SMC derived from different passages and 
from varying donors. 
We compared the effect of matrix proteins on 
SMC migration with that of the soluble growth factor 
PDGF-AB. We chose PDGF-AB because studies have 
shown that this is the predominant isoform found in 
human platelets. 13 With the exception of laminin 
matrix proteins were consistently more potent ago- 
nists of SMC migration than PDGF-AB. Although 
the magnitude of the response varied with each cell 
line tested, the chemotactic response of matrix pro- 
teins ranged from 4.5- to 21-fold that of cells in the 
control group, whereas PDGF-AB consistently pro- 
duced a t-wo- to threefold increase in SMC chemo- 
taxis. In separate xperiments we and others have 
observed that PDGF-BB produces a slightly greater 
(20% to 30%) migratory response than does 
PDGF-AB (data not shown). However, even the 
effect of PDGF-BB on SMC migration is much less 
than that observed with the two collagens. We have 
previously shown other soluble growth factors uch as 
epidermal growth factor and basic fibroblast growth 
factor to be less potent agonists of SMC migration 
than PDGF-AB. 9 These findings uggest that matrix 
proteins may be the predominant s imulus for the 
SMC migration that occurs after arterial injury. 
Of the three stimuli for migration we consistently 
found that the most profound effect on migration 
occurred when SMCs were stimulated by a gradient of 
insoluble matrix protein (haptotaxis). This observa- 
tion was consistent for all four matrix proteins, and the 
response to haptotaxis was on average 33% greater 
than the response of SMC to chemotaxis for the same 
agonist. Haptotaxis has been best studied in models of 
neoplasia. Because extracellular matrix proteins are 
most often present in vivo in insoluble form, hapto- 
taxis is thought to play a significant role in the invasion 
and metastatic spread of malignant tumors. From 
these studies itappears that haptotaxis and chemotaxis 
are not simply extensions of one another but com- 
pletely separate processes) 4 In fact, recent studies 
show that he signaling pathways responsible for these 
different mechanisms ofstimulation may be distinct. 
In the case of thrombospondin, haptotaxis and 
chemotaxis are mediated by completely separate pep- 
tide domains) 5 
Because activation of G-proteins has been found 
to be necessary for matrix-induced chemotaxis and 
haptotaxis of several tumor cell lines, we evaluated the 
importance of G-proteins in matrix-driven migration 
of human SMCs. CT, which adenosine diphosphate 
ribosylates and leads to persistent activation of Gs, 
dramatically inhibited migration to all matrix proteins 
and migration of ceils in the control group. These 
effects imply may be related to the increased levels of 
cAMP that are produced by persistent activation of 
Gs. 1° This hypothesis i  supported by previous obser- 
vations that stimulation of SMC with direct agonists 
of cAMP such as forskolin and 8-bromo-cAMP in- 
hibited migration) 6 
PT, which inhibits at least three subtypes of G~ 
(Gi> Gi2 , and Gi3) by uncoupling these proteins from 
their receptors, 1°had varying effects on SMC migra- 
tion that differed with each matrix protein and with 
the stimulus for migration. Activation ofG i appears to 
be essential for chemotaxis by laminin and partially 
necessary for haptotaxis by this same protein. Neither 
chemotaxis nor haptotaxis to the collagens or fi- 
bronectin was influenced by inhibition of G i. From 
these data we conclude that signaling pathways for the 
various matrix proteins differ and that at least for 
laminin signaling pathways for the various timuli for 
migration (haptotaxis versus chemotaxis) may also be 
distinct. Aznavoorian et al. 17 also found a differential 
role for G-proteins in migration of a melanoma cell 
line that was dependent on the matrix protein and the 
stimulus for migration. 
Our findings how that the ECM has a profound 
influence on SMC migration and that the magnitude 
of this effect is significantly greater than that of 
previously studied growth factors. Collagen types I
and IV, both of which are plentiful in the vessel wall, 
are the most potent agonists of migration, with 
laminin having the least significant influence. Stimu- 
lation through aptotaxis has a much greater effect on 
cellular motility than either chemotaxis or chemoki- 
nesis. The signaling pathways used by ECM proteins 
may vary with each specific protein and with each 
mechanism of stimulation. 
Migration is an essential component ofthe intimal 
hyperplastic process. Therefore inhibition of migra- 
tion might prevent he formation of hyperplastic 
lesions that so often complicate vascular econstruc- 
tion. We have found that SMC migration isinfluenced 
by matrix proteins to an even greater degree than by 
growth factors uch as PDGF. These findings uggest 
that attention should be focused on designing inhibi- 
tors that effect SMC/matrix protein interactions. 
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D ISCUSSION 
Dr. Al lan D. Cal low (Boston, Mass.). I think this is a 
splendid article for many reasons, and I congratulate you, 
Dr. Nelson, and your colleagues for calling attention to 
those methods and phenomena that probably will lead to 
the solution of  the problem of restenosis. I admire your 
courage. You have taken on so many different mechanisms 
and several proteins. 
We know that extracellular matrix does modify the 
phenotype of the SMC, Has the phenotype of the vascular 
SMC already been altered in the course of your processing? 
If  it has been altered, then it is now presumably secretory 
rather than contractile. Therefore it may be contributing to 
the source of the agonist, that is, the collagen that you say 
is so effective here. 
Second, what type of collagen do you have? Is it an 
active? Is it cross-linked? Is it denatured? What was the 
source of  your collagen? 
And third, I am curious why you chose the collagen you 
did. You did not study collagen type III, nortropoelastin, 
which are prominent in these phenomena. 
Dr. Peter R. Nelson (Boston, Mass.). The first ques- 
tion you referred to points to the limitation of  using 
cultured cell model. We use human vascular SMCs from 
saphenous vein. They are extracted by explant from rem- 
nant portions of saphenous vein left over from aortocoro- 
nary or peripheral vascular procedures. 
Dr. Callow. Could you tell us how you extracted them? 
My point is, what is the stage, the status of  the SMC by the 
time you have obtained it and put it into your model? 
Dr. Nelson. We extract them by a standard explantation 
technique where the adventitial and intimal layers are 
scraped away and then the remaining medial portion is 
placed into a dish and allowed for outward growth ofSMCs. 
Once the cells have grown out to a sufficient area, we harvest 
those cells with trypsin and potentiate cultures from there 
on out. 
The question of  whether we have altered cells by 
definition that we have now cultured them and whether 
they are in a proliferative versus a quiescent phase, two 
things come to mind. First of all, our cells are made 
quiescent before the study so that we starve the cells for 72 
hours in serum-flee media, so they are both confluent in a 
dish and are starved for 72 hours, and we have actually done 
previous cell cycle analysis in the laboratory to show that 
those are truly quiescent cells at the time of initiating the 
experiment. 
As to the next question, which was the source of the 
collagen, we do not get our collagen from any special 
source. It is commercially available collagen from Sigma 
Corporation, who provides it to us, so there is nothing 
special about our collagen preparation. 
In terms of our choice of  proteins that we studied, there 
was no specific reason not to include collagen type III. 
There have been a number of  studies with any one of  the 
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proteins or an occasional comparison study of two of the 
proteins, arid we compiled those data to arrive at these four 
proteins to try to in some ways producc an ovcrview 
comparison study. 
Dr. Michael S. Conte (New Haven, Conn.). I have two 
questions. ]First, as you may know, in a number of recent in 
vivo studies, interference with cell cycle-regulating proteins 
has had broad phenotypic effects on vascular smooth- 
muscle cclls including migration. I wonder if you could 
comment on how you synchronized your cells in rclation to 
the cell cycle. Did you deprive them of serum before you 
started your experiments? 
And the second question. I may have missed some of the 
mcthod, but could you comment on a role for PDGF? 
Certainly in vivo PDGF does not act alone in the absence of 
matrix proteins. Did you look at the combination of PDGF 
with matrix proteins, which might be more relevant to thc 
clinical situation? 
Dr. Nelson. The serum starvation question I already 
addressed toa point, but to stress, what we do is, the cells are 
grown in culture, and we use passage cells from passage one 
through passage four, so these are early passage cells, and 
they are serum-starved for 72 hours. Cell cycle analysis has 
shown that even before 72 hours these cells are quiescent, 
and so that 72 hours may be even a little bit excessive, but 
that has been our practice. 
In terms of the PDGF and extracellular matrix combi- 
nation question, that by chance is a very interesting question 
that I have bccn looking at more recently in my studies, and 
although I do not have data to present here, I hope at some 
coming conference I may be able to bring some interesting 
data for you. Preliminarily speaking, it seems that combi- 
nations of extracellular matrix and PDGF produce not only 
an enhanced response, and what I mean by that is the 
response that we get is more than a simple additive response 
between proteins, so if you took the effect from any of our 
data here for the matrix proteins and you added to that the 
magnitude of the PDGF effect, in combining both, coin- 
cubating both proteins in the experiments, we have been 
able to show that you get a synergistic effect, so the resultant 
migration is higher than what you would normally anti- 
cipate. 
Dr. Bauer E. Sumpio (New Haven, Conn.). Very 
interesting study. I would like to make a quick comment so 
I can ask two quick questions. 
The comment here is, I guess you are alluding to it in 
this study, and that is the interface that occurs between the 
substrate and cell. It is clear from seminal work done 5 years 
ago by Joe Madri and also by Folkman that the substrate on 
which these cells are cultured will influence their phenotype, 
and in this case you have shown the migration. Right at that 
interface there is an important structures. It is called the 
focal adhesion plaque, and this is really where the cell makes 
contact with the substrates, and right in that focal adhesion 
plaque are so-called integrins, which bind specifically to 
certain substances on the matrix and in turn lead to sort of 
the outside/inside signaling mechanism that you have 
alluded to in your guanosine triphosphate analysis. So the 
question I have is, does the integrin pattern in SMCs 
correlate with the findings that you found in terms of their 
migration on the different ypes ofsubstrates, that is, there 
are specific integrins that bind to laminin and fibronectin, 
and hence could one predict on the basis of the density and 
distribution of these integrins that you would see this 
pattern of migration? 
The second question is, in terms of the signaling aspect 
that you are alluding to with your guanosine triphosphate, 
are you alluding to the small guanosine triphosphate- 
binding protein rho, which is part of the cascade that occurs 
from these focal adhesion plaques? 
Dr. Nelson. With regard to the first question, there has 
been a fairly large group of work done primarily in neoplas- 
tic cells again but also in vascular cells looking at specifically 
the integrins and the combinations of the various compo- 
nents composing the integrin receptor in terms of the 
specificity for the various matrix surfaces. We ourselves in 
our laboratory have not looked specifically at the integrins 
and their role in terms of the attachment toand subsequent 
signaling of the matrix proteins. The focal adhesion com- 
plex that you mentioned is actually an interest in our 
laboratory. One of the other investigators has been looking 
at the focal adhesion complex, and the plans at this point are 
to combine some of my interests and some of their interests 
and try to sort that out for a vascular cell model. 
In terms of the small G protein rho, that is not what I am 
referring to in terms of my study. What we are looking at are 
the larger G proteins that are essentially known to transfer 
the signal from membrane receptors to subsequent signal- 
ing mechanisms. One particularly is the cyclic AMP or 
adenylate cyclase pathway. In those pertussis toxin inhibits 
the inhibitory subunit or inhibitory subtype of those large G 
proteins, and cholera toxin inhibits the stimulatory subtype. 
Obviously that is a larger discussion, but essentially we are 
looking at the large G proteins. Others in our laboratory are 
also looking at rho, and our laboratory feels very strongly 
that rho plays a very significant role in the signaling 
mechanism specifically for SMC migration. 
